Ansornitinib

DB21577ExperimentalSmall molecule

Ansornitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Ansornitinib is a tyrosine kinase inhibitor. Ansornitinib has a monoisotopic molecular weight...

Formula / weight: C₃₀H₃₂N₆O₄ · 540.624 g/mol (avg)

Resolves to

Compound

UNIILHC4W5LJH4CAS1448874-96-1ChEMBLCHEMBL5095090ChEBI758674

Structure

InChIKeyOABALTWKAJWHEA-RQZHXJHFSA-NSMILESCOC(=O)C1=NC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2

Which companies are running trials of Ansornitinib, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account